Which antibiotic can be safely given with leflunomide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antibiotics Safe with Leflunomide

Most antibiotics can be safely given with leflunomide, but rifampin should be avoided as it significantly increases leflunomide levels, and careful monitoring is required when combining leflunomide with hepatotoxic antibiotics like isoniazid.

Key Drug Interactions

Rifampin - AVOID

  • Rifampin increases leflunomide levels and should not be used concurrently 1, 2, 1
  • This interaction is specifically highlighted in FDA labeling and multiple guidelines
  • If tuberculosis treatment is necessary, alternative regimens should be considered

Isoniazid - Use with Caution

  • When treating latent tuberculosis with isoniazid in patients on leflunomide, intensive liver function monitoring is mandatory 3
  • Both drugs are hepatotoxic, creating additive risk
  • Monitor LFTs monthly during co-administration rather than the standard every 6-8 weeks 3

Methotrexate Considerations

  • While methotrexate is not an antibiotic, the FDA label notes that leflunomide plus methotrexate shows no pharmacokinetic interaction but increases hepatotoxicity risk 1, 4
  • This principle applies to any hepatotoxic antimicrobial agent

Safe Antibiotic Options

The following antibiotics have no documented problematic interactions with leflunomide:

  • Beta-lactams (penicillins, cephalosporins, carbapenems) - no interactions documented 5, 6, 7
  • Fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) - safe to use 5, 7
  • Macrolides (azithromycin, clarithromycin) - no documented interactions 5
  • Tetracyclines (doxycycline, minocycline) - safe 5
  • Aminoglycosides (gentamicin, tobramycin) - no interactions 6
  • Metronidazole - safe for anaerobic coverage 6
  • Vancomycin and linezolid - no documented interactions 5

Monitoring Requirements

Standard monitoring for leflunomide continues during antibiotic therapy:

  • CBC with differential and LFTs monthly for first 6 months, then every 6-8 weeks 8, 2, 1
  • Increase monitoring frequency to monthly if using hepatotoxic antibiotics like isoniazid 3

Special Considerations

Acyclovir Interaction

  • Research shows leflunomide increases kidney accumulation of acyclovir by inhibiting renal transporters (OAT1/3 and MRP2) 9
  • This increases acyclovir's plasma concentration and kidney/plasma ratio
  • While not contraindicated, monitor renal function more closely when combining these agents
  • Consider dose adjustment of acyclovir if renal function changes

Immunosuppression Context

  • Leflunomide increases infection risk through immunosuppression 8, 1
  • The need for antibiotics may be more frequent in leflunomide-treated patients
  • Leflunomide has some intrinsic antiviral properties, which may be beneficial 10

Clinical Algorithm

When prescribing antibiotics to a patient on leflunomide:

  1. Avoid rifampin - choose alternative TB regimen if needed
  2. For common infections - use standard antibiotics (beta-lactams, fluoroquinolones, macrolides) without dose adjustment
  3. For TB treatment with isoniazid - increase LFT monitoring to monthly
  4. For acyclovir - monitor renal function closely
  5. Continue baseline leflunomide monitoring throughout antibiotic course

References

Guideline

recommendations and guidelines for the treatment of pneumonia in taiwan.

Journal of Microbiology, Immunology and Infection, 2019

Research

Leflunomide: Traditional immunosuppressant with concurrent antiviral effects.

International journal of rheumatic diseases, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.